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BD = bronchopulmonary dysplasia; IL = interleukin; RDS = respiratory distress syndrome; SP = surfactant protein; T4 = plasma thyroxine; TGF =
transforming growth factor; TNF = tumor necrosis factor.
Available online http://respiratory-research.com/content/2/1/027
Introduction
Recent information supports the concept that
infection/inflammation resulting in preterm delivery can
promote both early lung maturation and lung injury. As
Fig. 1 illustrates, the lung continues to develop after
preterm birth. The human lung undergoes a transition from
the canalicular stage to the saccular stage of development
at about 22 weeks, and alveolarization by secondary
septal formation does not begin until about 30–32 weeks
gestation [1]. Therefore, both clinical events in fetal life
before preterm birth at 26 weeks gestation (65% of gesta-
tion) and preterm birth itself have the potential to adversely
or beneficially influence lung function and the outcome of
the infant. One of the themes of this review is that pro-
inflammation is common to many of the events that occur
with preterm birth, neonatal adaptation to air breathing,
and subsequent lung function. The details of the modula-
tion of lung injury and maturation by pro-inflammation have
not yet been identified, and much of what follows is hypo-
thetical and occasionally speculative. However, the epi-
demiologic information, some of the clinical associations,
and the initial investigative work with model systems
support the need for further research in this area.
Antenatal infection/inflammation, preterm
delivery, and brain injury
Preterm fetuses infected with virulent organisms such as
Escherichia coli, Group B Streptococcus or Listeria
monocytogenes have sepsis/pneumonia syndromes.
However, such presentations are rare before 30 weeks
gestation. In contrast 50% or more of fetuses delivered
before 30 weeks gestation have chronic chorioamnionitis,
as indicated by histologic examination of the fetal mem-
branes and cord, cell counts in the amniotic fluid, or
culture positivity for vaginal and commensal organisms
that are not generally considered pathologic [2•]. More
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surprisingly, many of these fetuses may have been
exposed to low-grade inflammation for prolonged periods,
possibly beginning with colonization of the uterine tissue
prior to conception. For reasons that are presently
unknown, these pregnancies do not present with preterm
labor before 20 weeks gestation, even if the amniotic fluid
was positive for pro-inflammatory cytokines or organisms
prior to the preterm labor.
These very preterm deliveries are the major contributors to
postnatal morbidities and mortality, with the most common
acute morbidities being brain injury and lung injury. The
infants seldom have positive blood cultures after delivery,
implying that infections had been isolated to the uterus,
placenta, and/or fetal membranes. However, more recent
information indicates that exposure to intrauterine infec-
tion/inflammation results in more serious injury than the
preterm delivery alone. Although not the topic of this
review, the major concern is that indicators of intrauterine
inflammation may be associated with periventricular leuko-
malacia and subsequently cerebral palsy. Chorioamnionitis
correlates with subsequent brain injury, and the presence
of the pro-inflammatory cytokines interleukin-6 (IL-6), inter-
leukin-1b (IL-1b), or tumor necrosis factor a (TNF-a) in
amniotic fluid before preterm delivery predicts subsequent
brain injury [3,4]. The fetus may respond to intra-amniotic
infection with a systemic inflammatory response (defined
as elevated IL-6 in plasma) and preterm infants with such
a response are at increased risk of subsequent brain injury
[5,6]. Therefore, factors associated with antenatal infec-
tion/injury increase the risk of brain injury after preterm
birth, and this association may also explain much of the
cerebral palsy that occurs after term birth [7].
Antenatal infection/inflammation and lung
injury
The fetal lung is also a target for factors released by ante-
natal infection/inflammation. Most infants born after
amnionitis do not have either positive tracheal cultures or
a clear pneumonic process. However, as with the brain,
lung injury progressing to bronchopulmonary dysplasia
(BPD) can occur after exposure to either elevated pro-
inflammatory cytokines in amniotic fluid or a systemic
inflammatory response [5,8••]. Yoon et al correlated ele-
vated levels of IL-6 in cord plasma with the subsequent
development of BPD after preterm birth [9]. Elevated
levels of IL-6, IL-1b, IL-8, and TNF-a in amniotic fluid within
5 days of preterm birth also predicted the subsequent
development of BPD [8••]. The most common commensal
organism associated with histologic chorioamnionitis after
very preterm birth is Ureaplasma urealyticum [2], which
induces a robust pro-inflammatory response characterized
by elevations of the previously listed cytokines in the amni-
otic fluid [10]. Infants colonized with Ureaplasma at birth
subsequently had a 43% incidence of BPD, in contrast to
a comparison group with an incidence of 19% [11]. In
another report, histologic chorioamnionitis was associated
with an increased incidence of BPD, while the infants that
developed it had elevated cytokine levels in tracheal aspi-
rates on the first day after birth.
Figure 1
Lung development must continue for survival of the very low birth weight infant after preterm delivery at 26 weeks. Antenatal infection/inflammation
associated with chorioamnionitis can modulate lung development, as can postnatal causes of inflammation such as mechanical ventilation,
supplemental oxygen, or infection. The stages of lung development are modified from Burri [1].c
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There are other reports of the association between indica-
tors of antenatal infection/inflammation and subsequent
lung injuries of various types after preterm birth. Matsuda
et al reported that infiltration of the cord by white blood
cells predicted BPD in infants [12]. Increased leukocyte
elastase in tracheal aspirates at birth predicted the subse-
quent development of pulmonary emphysema, characteris-
tic of the Wilson-Mikity variant of BPD [13]. Raised levels
of amniotic fluid TNF-a correlated with an increased inci-
dence of respiratory distress syndrome (RDS) [14]. In an
autopsy series, about 50% of very low birth weight infants
that died shortly after birth had histopathologic evidence
of pulmonary infection/inflammation [15]. Not all reports
found a striking relationship between antenatal
infection/inflammation and subsequent lung injury. Vari-
able outcomes probably result from the amount and dura-
tion of antenatal exposure to inflammation/infection and
the fetal responses.
The link between inflammation/infection and
BPD
The initial description of BPD by Northway, Rosan, and
Porter [16] identified barotrauma and oxygen exposure as
the causes of airway injury, fibrosis, and emphysema in
ventilated preterm infants. Experimental models demon-
strated that either barotrauma or oxygen exposure could
cause lung injuries similar to BPD. Recently, inflammation
characterized by activated recruitment of white blood cells
to the lungs and pro-inflammatory cytokine production has
been identified as common to both oxidant injury and
barotrauma in the lungs of the adult and the developing
infant [17–19]. Most infants that develop BPD weigh less
than 1kg at birth and are born before 28 weeks gestation.
The unique aspect that distinguishes BPD from other lung
injuries is that the injury is superimposed on a lung that is
in the saccular stage of development. Fibrosis, airway
injury, and emphysema are all minimal in infants who have
died of BPD, with the dominant abnormality being an
arrest in alveolar and microvascular development [20•,21]. 
These anatomic findings can be reproduced in experimen-
tal models by oxygen exposure and ventilation. For
example, newborn mice exposed to 85% oxygen develop
inflammation and an arrest in secondary septation [19].
Preterm baboons ventilated for 7 days with 100% oxygen
from 140-day gestation have fewer and larger alveoli,
when evaluated as young adults [22]. Therefore high and
prolonged oxygen exposure can arrest alveolar develop-
ment. More clinically relevant are the observations that an
arrest in alveolar and vascular development occurs in sur-
factant-treated preterm lambs and 125-day gestation
baboons that are chronically ventilated with just sufficient
pressure to maintain normal gas exchange, using supple-
mental oxygen at less than 50% [23••,24••]. Airway
samples from these animals contain elevated levels of a
variety of pro-inflammatory mediators and inflammatory
cells. Therefore, ventilatory support similar to that used for
preterm infants can arrest lung development.
The mediators that interfere with lung development are not
known, nor are the normal modulators of the alveolariza-
tion process. However, there is information from trans-
genic mouse models that inflammatory mediators can
interfere with postnatal alveolarization. Overexpression of
TNF-a, transforming growth factor a (TGF-a), IL-11, or IL-
6 in the lungs of developing mice results in variable
pathologies that have in common an interference with
alveolarization [25]. Infants destined to develop BPD have
elevated levels of IL-1b, TNF-a, IL-8, and of multiple other
cytokines, chemokines, and other promotors and products
of inflammation in their airways soon after birth, and these
markers of inflammation persist [26]. Preterm infants who
develop sepsis or sepsis/pneumonia also are at increased
risk of developing BPD [27]. Those born after exposure to
amnionitis who also have a systemic inflammatory
response, as defined by elevated IL-6 levels in cord blood,
have an increased risk of developing BPD [9], as do
infants born after exposure to elevated levels of IL-6, IL-8,
IL-1b, and TNF-a in the amniotic fluid [8]. The anti-inflam-
matory cytokine IL-10 was undetectable in airway samples
of preterms, which may strengthen the predisposition to
persistence of chronic inflammation [28].
The inflammatory response is complex and no single com-
ponent has been identified as being of primary importance
in promoting lung injury or inhibiting alveolarization in the
preterm. The preterm lung will differ in injury and immune
responses from the adult lung because it contains almost
no macrophages and has low levels of innate host defense
elements, such as the surfactant proteins SP-A and SP-D,
defensins, and lysozyme. Also, the white blood cells of the
preterm show less response to inflammatory stimuli than
their counterparts in the adult. There is a lack of informa-
tion about how the preterm lung initiates and sustains
inflammatory responses: information that is central to
understanding injury progression to BPD, resulting in a
disruption of alveolar and vascular development. The
common theme is that inflammation interferes with alveo-
larization, but cause and effect have not been demon-
strated. Also, alveolarization can be delayed by
anti-inflammatory effectors such as glucocorticoids and by
non-specific stresses such as caloric deficits. Alveolariza-
tion can also be stimulated or promoted by agents such as
plasma thyroxine (T4) and retinoic acid [29]. The regulation
of alveolarization remains to be understood. 
Infection/inflammation and lung maturation
Fetal or neonatal exposure that can result in lung and
brain injury is consistent with the general understanding
that severe and chronic inflammation is damaging.
However, the preterm fetus can apparently also benefit
from an antenatal inflammatory stimulus. The clinical
Available online http://respiratory-research.com/content/2/1/027associations are not consistent in all reports, but are strik-
ing in several series. In a recent report of the outcomes of
all infants born in England at less than 26 weeks gesta-
tion in 1995, chorioamnionitis was independently associ-
ated with decreased death (odds ratio 0.51, P < 0.005)
[30]. Watterberg et al [31•] reported that infants born to
women with histologic chorioamnionitis had a decreased
incidence of RDS but an increased incidence of BPD, rel-
ative to infants born to women without chorioamnionitis.
The infants from the pregnancies with chorioamnionitis
had elevated IL-1b levels in tracheal aspirates. Ure-
aplasma, the organism most frequently associated with
chorioamnionitis, elevates cytokines in amniotic fluid, and
colonization of preterm infants has been associated in
some series with BPD. Hannaford et al [11] found that
infants colonized at birth with Ureaplasma had signifi-
cantly less RDS in the early neonatal period, but pro-
gressed to having significantly more BPD than
uncolonized preterm infants. These selected examples of
an association between inflammation and decreased
RDS after preterm delivery but increased BPD are coun-
terintuitive because in general RDS is thought to be the
major predictor of BPD. However, it is now common in
clinical practice to encounter very preterm infants with
little or no RDS who progress to BPD [32,33]. The ante-
natal histories of these infants have not been well
described, but it would seem reasonable to hypothesize
that antenatal infection/inflammation may induce a pro-
inflammatory response that is not appropriately sup-
pressed after delivery, resulting in BPD.
The mechanisms that explain how inflammation/infection
can induce lung maturation remain to be worked out, but
there is some information demonstrating that pro-inflam-
matory cytokines can modulate lung development. Bry et
al reported that intra-amniotic IL-1a induced the surfac-
tant protein mRNAs for SP-A and SP-B, increased surfac-
tant lipids, and improved the pressure-volume curves of
preterm rabbits in a dose-dependent fashion [34••]. In
vitro IL-1a induces the mRNAs for SP-A, SP-B, and SP-C
in rabbit lung explants from 19-day and 22-day fetuses,
but suppresses surfactant mRNAs in lung explants from
27-day or 30-day fetuses, demonstrating that the
cytokine effect is gestation-specific [35]. In an initial
experiment, 125 mg of human recombinant IL-1a, given
by intra-amniotic injection, increased surfactant lipids and
improved the pressure-volume curves of preterm sheep,
without increasing fetal cortisol or altering postnatal
kidney function [36]. Therefore, a single pro-inflammatory
cytokine can promote changes consistent with lung matu-
ration. However, IL-1a and endotoxin share common sig-
naling pathways, and when intra-amniotic recombinant
sheep IL-1a or IL-1b is given to sheep, it causes amnioni-
tis (Jobe and Ikegami, unpublished data). Other mediators
induced as part of this response could be modulating
lung development.
In experiments designed to model clinical chorioamnionitis
in sheep and to evaluate the lung responses, we used E.
coli 055/b5 endotoxin as the pro-inflammatory stimulus
[37•]. The intra-amniotic endotoxin induces IL-1b, IL-6,
IL-8, and to a lesser extent TNF-a in the amnion/chorion
within 5 hours. This cytokine response extinguishes within
2 days, but the numbers of inflammatory cells in the
amnion/chorion remain elevated for many days [38].
Cytokine mRNA elevations are detected in the fetal lung 5
hours after exposure to intra-amniotic endotoxin and the
greatest increases in cytokine mRNA are at 1–2 days, with
baseline levels measured by 4 days. The systemic
response to the intra-amniotic endotoxin is very modest,
with no increases in fetal plasma cortisol and a small
decrease in circulating white blood cells at 1–2 days, fol-
lowed by an increase by 4–7 days. 
Several aspects of the inflammatory response to intra-
amniotic endotoxin are remarkable: there is no cytokine
response in the placenta, liver, or gut, and there is no
response at all if the endotoxin was injected into allantoic
fluid. The fetal lung responds with increased mRNAs for
SP-A, SP-B, SP-C, and SP-D by 1 day (a 6-fold increase
for SP-A), with these increased mRNA levels persisting
for 15 days after a single intra-amniotic injection of 20 mg
of endotoxin [39]. The surfactant proteins in alveolar
washes are beginning to increase 4 days after the endo-
toxin stimulus and have increased 100-fold from control
values by 7 days. The fetal sheep at 125-day gestation
has very little SP-B in the airspaces and only about 25%
of this is the fully processed mature peptide. Intra-amni-
otic endotoxin induces processing of SP-B and a 100-
fold increase in mature SP-B in the airspaces within 7
days. The saturated phosphatidylcholine in alveolar
washes increases in parallel with the surfactant proteins,
and compliance and pressure-volume curves are
improved by 4 days after exposure to intra-amniotic endo-
toxin [40]. The lung responses are equivalent over a dose
range of 1–100 mg of endotoxin, and the lung responses
indicative of maturation correlate with inflammatory
responses in the amnion/chorion and in lung tissue.
These studies suggest that components of the inflamma-
tory response are inducing lung maturation, although we
are a long way from demonstrating cause and effect.
Antenatal glucocorticoids are inducers of early lung matu-
ration that are used clinically. Watterberg et al [41] pro-
posed that lung maturation was induced by the elevation
of fetal cortisol levels by stress from amnionitis. At least in
the fetal sheep model, intra-amniotic endotoxin does not
increase fetal plasma cortisol [40], which means that other
mediators are responsible for the effects of endotoxin on
the fetal lung.
These experiments are consistent with the clinical obser-
vations that amnionitis can be associated with a decrease
Respiratory Research    Vol 2 No 1 Jobe and Ikegamiin RDS. The relationship between fetal exposure to inflam-
mation and its subsequent association with BPD needs to
be clarified. In adult lungs, prior exposure to endotoxin will
result in an amplified inflammatory response to mechanical
ventilation [42]. The initiation of mechanical ventilation of
the preterm lung will recruit activated granulocytes to it,
even with surfactant treatment and gentle ventilation. It can
be hypothesized that ventilation or oxygen exposure of an
inflamed preterm lung may aggravate and perpetuate the
injury process [43]. The irony is that this effect may occur
to a lung that has profited in the short term by being more
mature, as a result of exposure to inflammation in utero. 
BPD in tiny preterm infants is primarily an arrest of alveolar
development. Antenatal glucocorticoids can arrest alveo-
larization in animals that initiate alveolarization before birth
[29]. In sheep, alveolar development is arrested compara-
bly by maternal betamethasone or intra-amniotic endotoxin
given 7 days before preterm delivery [44]. The compo-
nents of the inflammatory response that disrupt alveolar
development in the fetal lung remain to be identified. With
a bit of luck, the factors that favor maturation may be dif-
ferent from those that promote injury. However, the basic
biologic question is: Can the lung have induced matura-
tion without its subsequent development suffering? Put in
practical terms: Does the lung that matures early have the
same number of alveoli and capillaries as the normal adult
lung and does it respond similarly to stresses? Answers to
these questions are not available.
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